110 related articles for article (PubMed ID: 1823398)
1. High-dose-rate intraluminal brachytherapy for postoperative residual tumor of gallbladder carcinoma: a case report.
Kurisu K; Hishikawa Y; Taniguchi M; Kamikonya N; Miura T; Kanno H; Okamoto E
Radiat Med; 1991; 9(6):241-3. PubMed ID: 1823398
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy of postoperative residual tumor of bile duct carcinoma.
Kurisu K; Hishikawa Y; Miura T; Kanno H; Okamoto E
Radiat Med; 1991; 9(2):82-4. PubMed ID: 1658858
[TBL] [Abstract][Full Text] [Related]
3. [Improved treatment results in advanced gallbladder and bile duct cancer by postoperative combined radiotherapy].
Jörling P; Schmid HU; Leber K; Haubold B; Junghanns K
Leber Magen Darm; 1992 May; 22(3):116-9. PubMed ID: 1625509
[TBL] [Abstract][Full Text] [Related]
4. Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas.
Dvorák J; Jandík P; Melichar B; Jon B; Mergancová J; Zoul Z; Vacek Z; Petera J
Hepatogastroenterology; 2002; 49(46):916-7. PubMed ID: 12143240
[TBL] [Abstract][Full Text] [Related]
5. Gallbladder cancer: role of radiation therapy.
Houry S; Haccart V; Huguier M; Schlienger M
Hepatogastroenterology; 1999; 46(27):1578-84. PubMed ID: 10430298
[TBL] [Abstract][Full Text] [Related]
6. Irradiation therapy for gallbladder carcinoma: recent advances.
Houry S; Barrier A; Huguier M
J Hepatobiliary Pancreat Surg; 2001; 8(6):518-24. PubMed ID: 11956902
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of patients with gallbladder cancer treated with radical resection versus cholecystectomy plus external radiotherapy.
Mondragón-Sánchez R; González-Geroniz M; Oñate-Ocaña LF; Garduño-López AL; Mondragón-Sánchez A; Bernal-Maldonado R; Ruiz-Molina JM
Hepatogastroenterology; 2003; 50(54):1806-10. PubMed ID: 14696410
[TBL] [Abstract][Full Text] [Related]
8. [Advanced hepatocellular carcinoma--feasibility and clinical impact of high-dose-rate brachytherapy on the treatment of lesions growing into biliary trees, portal veins and the vena cava].
Ii N; Yamakado K; Shoji K; Kihira K; Nomoto Y; Nakatsuka A; Takeda K
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1498-500. PubMed ID: 11707963
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate intraluminal brachytherapy for bile duct carcinoma after surgery.
Kurisu K; Hishikawa Y; Taniguchi M; Kamikonya N; Miura T; Kanno H; Okamoto E
Radiother Oncol; 1991 May; 21(1):65-6. PubMed ID: 1712977
[TBL] [Abstract][Full Text] [Related]
10. [Present status and possibilities of radiotherapy in the interdisciplinary treatment of malignant tumors of the stomach, pancreas and bile ducts. III. Extrahepatic bile ducts and gallbladder].
Köster R; Scherer E
Strahlentherapie; 1984 Jul; 160(7):403-10. PubMed ID: 6431648
[TBL] [Abstract][Full Text] [Related]
11. [Metallic mesh endoprosthesis and intraluminal high dose rate 192Ir brachytherapy in the palliative treatment of malignant bile duct obstruction. Initial results].
Pakisch B; Klein GE; Stücklschweiger G; Lammer J; Poier E; Leitner H; Poschauko J; Hausegger KA; Hackl A
Rofo; 1992 Jun; 156(6):592-5. PubMed ID: 1377518
[TBL] [Abstract][Full Text] [Related]
12. Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies--the question of long-term palliation.
Bruha R; Petrtyl J; Kubecova M; Marecek Z; Dufek V; Urbanek P; Kodadova J; Chodounsky Z
Hepatogastroenterology; 2001; 48(39):631-7. PubMed ID: 11462891
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.
Deodato F; Clemente G; Mattiucci GC; Macchia G; Costamagna G; Giuliante F; Smaniotto D; Luzi S; Valentini V; Mutignani M; Nuzzo G; Cellini N; Morganti AG
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):483-8. PubMed ID: 16242254
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
Hille A; Weiss E; Hess CF
Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
[TBL] [Abstract][Full Text] [Related]
15. Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors.
Schleicher UM; Staatz G; Alzen G; Andreopoulos D
Strahlenther Onkol; 2002 Dec; 178(12):682-7. PubMed ID: 12491056
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
17. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy of carcinoma of the gallbladder.
Hishikawa Y; Tanaka S; Miura T
Radiat Med; 1983; 1(4):326-9. PubMed ID: 6209750
[TBL] [Abstract][Full Text] [Related]
19. [Fundamental and clinical studies of preoperative radiotherapy with high-dose rate intraluminal brachytherapy].
Kamikonya N
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Aug; 51(8):950-61. PubMed ID: 1945777
[TBL] [Abstract][Full Text] [Related]
20. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung.
Mutignani M; Shah SK; Morganti AG; Perri V; Macchia G; Costamagna G
Endoscopy; 2002 Jul; 34(7):555-9. PubMed ID: 12170409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
